Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Tavin L Tablet
Manufacturer/Marketed By : EMCURE PHARMACEUTICALS LTD
$15.29 $9.98
Tavin L tablet consists of the active substance called Lamivudine, Tenofovir Disoproxil Fumarate, which belongs to the class of antiretroviral or Anti-Viral medicine. This medicine treats HIV (human immunodeficiency virus)...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
LAMIVUDINE,TENOFOVIR DISOPROXIL FUMARATE
Active Pharmaceutical Ingredient
Tavin L Tablet
15.29$
9.98$
Tavin L tablet consists of the active substance called Lamivudine, Tenofovir Disoproxil Fumarate, which belongs to the class of antiretroviral or Anti-Viral medicine. This medicine treats HIV (human immunodeficiency virus) infection. It is a nucleotide reverse transcriptase inhibitor (NRTI) and works by inhibiting the enzymes (HIV reverse transcriptase) important for virus replication. This tablet is not studied in patients over 65 years of age. Anti-Virals used for HIV infection are known as antiretrovirals. While consuming this medicine, you may still develop infections related to HIV. Although effective antiretroviral therapy reduces the risk, HIV transmission is still possible when using this medication. This tablet is not for use in children and adolescents under 18 years. Contact your doctor for more information. Do not consume Tavin L tablet if you have experienced allergic reactions to Lamivudine, Tenofovir Disoproxil Fumarate, peanuts, or soya, (as this medicine contains lecithin) or any of its other medical ingredients. During the treatment, your doctor may periodically monitor your blood counts, bone mineral density, liver and kidney parameters to prevent serious complications. Before beginning the treatment, notify your doctor if you have bone disease (osteonecrosis - the death of bone tissue), fractures, a history of the liver (chronic hepatitis B or C), or kidney problems. Your doctor may advise dose adjustment if you are a kidney patient. Reduce your dosage if only your doctor suggests it. Tavin L tablet should not be given to adolescents with existing kidney problems. Inform your doctor if you are planning to get pregnant or think you may be pregnant. Breastfeeding is not recommended due to the potential transmission of HIV from the mother to the baby. Always use effective contraception. Discuss with your doctor for more fertility concerns.
Active Pharmaceutical Ingredient
Uses
• Treatment of HIV infection
Benefits
Lamivudine and Tenofovir disoproxil fumarate inhibit the enzyme reverse transcriptase; inhibition of these enzymes blocks the reproduction of the virus and prevents the release of viral particles in the body to treat the HIV infection.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Most Common Side Effects
• Headache
• Stomach pain
• Tiredness
• Bloating, flatulence
• Low phosphate levels in the blood
• Diarrhea
• Dizziness
• Joint pain
• Sickness
• Rash
• Weakness
Common Side Effects
• Kidney damage
• Deep, rapid breathing
• Drowsiness
• Nausea, vomiting
• Lactic acidosis (excess lactic acid)
• Infection
• Increased liver enzymes
How To Use
Tavin L tablet are always taken at the dose recommended by your doctor or health care provider. Your physician will choose the dosage and administration frequency based on the medical condition because it differs for each person. Do not crush, chew or break the tablet.
Safety Advice
• Breast Feeding: It is unsafe to breastfeed if you are with HIV infection. Consult your doctor for more information about Tavin L tablet.
• Alcohol: Do not consume alcohol while taking the Tavin L tablet, as this injection may cause drowsiness with alcohol.
• Liver: Inform your physician about any underlying liver disorders before taking Tavin L tablet should be used with caution in liver disease patients. Your doctor may monitor your liver enzymes. Consult your physician before taking this medicine.
• Lungs: It is unknown whether Tavin L tablet is safe for patients with lung problems. Inform your physician if you have any lung disease before starting the treatment. Contact your doctor if you experience any lung-related symptoms.
• Driving: It is unsafe to drive while taking Tavin L tablet because this medicine might cause vision problems and tiredness, so avoid driving and operating machinery during this treatment.
• Pregnancy: Notify your healthcare professional if you are pregnant or planning to have a baby think you may be pregnant. Your physician will conduct regular tests to monitor the development of your child. Ask for suggestions before taking the Tavin L tablet.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.